Theileria parva candidate vaccine antigens recognized by immune bovine cytotoxic T lymphocytes
β Scribed by Graham, S. P.; Pelle, R.; Honda, Y.; Mwangi, D. M.; Tonukari, N. J.; Yamage, M.; Glew, E. J.; de Villiers, E. P.; Shah, T.; Bishop, R.; Abuya, E.; Awino, E.; Gachanja, J.; Luyai, A. E.; Mbwika, F.; Muthiani, A. M.; Ndegwa, D. M.; Njahira, M.; Nyanjui, J. K.; Onono, F. O.; Osaso, J.; Saya, R. M.; Wildmann, C.; Fraser, C. M.; Maudlin, I.; Gardner, M. J.; Morzaria, S. P.; Loosmore, S.; Gilbert, S. C.; Audonnet, J.-C.; van der Bruggen, P.; Nene, V.; Taracha, E. L. N.
- Book ID
- 121753021
- Publisher
- National Academy of Sciences
- Year
- 2006
- Tongue
- English
- Weight
- 827 KB
- Volume
- 103
- Category
- Article
- ISSN
- 0027-8424
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Cytotoxic T lymphocyte (CTL) clones directed against autologous renal-cell carcinoma (RCC) cell lines were generated by mixed lymphocyteltumor-cell culture (MLTC) using peripheral blood lymphocytes (PBL). A CD8+, C W -CTL clone MZI257-CTL 5/30 with high cytolytic act-kity for the autologous tumor ce